Scientific Reports (Dec 2023)

Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function

  • Sohvi Ohtonen,
  • Luca Giudice,
  • Henna Jäntti,
  • Mohammad Feroze Fazaludeen,
  • Anastasia Shakirzyanova,
  • Mireia Gómez-Budia,
  • Nelli-Noora Välimäki,
  • Jonna Niskanen,
  • Nea Korvenlaita,
  • Ilkka Fagerlund,
  • Jari Koistinaho,
  • Mahmood Amiry-Moghaddam,
  • Ekaterina Savchenko,
  • Laurent Roybon,
  • Šárka Lehtonen,
  • Paula Korhonen,
  • Tarja Malm

DOI
https://doi.org/10.1038/s41598-023-49294-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

Abstract LRRK2-G2019S is one of the most common Parkinson’s disease (PD)-associated mutations and has been shown to alter microglial functionality. However, the impact of LRRK2-G2019S on transcriptional profile of human induced pluripotent stem cell-derived microglia-like cells (iMGLs) and how it corresponds to microglia in idiopathic PD brain is not known. Here we demonstrate that LRRK2-G2019S carrying iMGL recapitulate aspects of the transcriptional signature of human idiopathic PD midbrain microglia. LRRK2-G2019S induced subtle and donor-dependent alterations in iMGL mitochondrial respiration, phagocytosis and cytokine secretion. Investigation of microglial transcriptional state in the midbrains of PD patients revealed a subset of microglia with a transcriptional overlap between the in vitro PD-iMGL and human midbrain PD microglia. We conclude that LRRK2-G2019S iMGL serve as a model to study PD-related effects in human microglia.